SCHEDULE 13D/A: QH Hungary Amends Share Forward Deals, Raises Capital

QH Hungary Holdings Limited updated its Schedule 13D filing, detailing amendments to existing prepaid variable share forward transactions and new agreements with Citibank and Royal Bank of Canada to extend settlement dates and raise financing.

Summary

• QH Hungary Holdings Limited, a subsidiary of Gulf Hungary Holding Korlatolt Felelossegu Tarsasag, filed Amendment No. 39 to its Schedule 13D regarding its beneficial ownership in Quaker Chemical Corporation.
• The filing details several transactions on November 25, 2025, involving prepaid variable share forward transactions with Citibank, N.A. and Royal Bank of Canada.
• Two existing supplemental confirmations (Eighth Citi and Fifth RBC) were amended and restated, extending settlement dates.
• For the amended Citibank confirmation, QH Hungary paid Citibank $3,246,816 and delivered 45,000 shares, reducing the covered shares to 192,200.
• For the amended Royal Bank of Canada confirmation, QH Hungary paid RBC $2,164,547 and delivered 30,000 shares, reducing the covered shares to 128,133.
• Two new supplemental confirmations (Tenth Citi and Seventh RBC) were entered into to raise financing.
• Citibank paid QH Hungary $1,699,801 for the new Citibank confirmation covering 13,900 shares.
• Royal Bank of Canada paid QH Hungary $1,133,241 for the new Royal Bank of Canada confirmation covering 9,267 shares.
• All these transactions involve a Forward Floor Price of $139.28 and a Forward Cap Price of $153.21, with settlement dates ranging from November 29, 2027, to January 3, 2028.
• QH Hungary retains the option to settle its obligations by delivering shares or the cash equivalent.
• The reporting persons, Gulf Hungary and QH Hungary, beneficially own 3,640,129 and 3,635,112 shares respectively, representing 21.0% of Quaker Chemical Corporation's outstanding common stock.

Sentiment

Score: 6

Explanation: The filing indicates ongoing financial management and strategic use of equity holdings for financing and extending obligations. While there are costs associated with amending existing agreements, the ability to raise new capital and extend terms suggests a degree of financial flexibility and strategic planning by the reporting person. It's a neutral to slightly positive event for the reporting person's financial strategy, but not directly impacting the issuer's operational performance.

Positives

• QH Hungary successfully raised additional financing of $1,699,801 from Citibank and $1,133,241 from Royal Bank of Canada through new prepaid variable share forward transactions.
• The amendments to existing transactions extended settlement dates, providing more flexibility for QH Hungary.
• QH Hungary maintains the option to settle obligations in shares or cash, allowing for strategic flexibility based on future share price performance.
• The transactions are designed to allow QH Hungary to share in the Issuer's future growth while raising financing.

Negatives

• QH Hungary made significant payments to Citibank ($3,246,816) and Royal Bank of Canada ($2,164,547) and delivered 75,000 shares (45,000 to Citibank, 30,000 to Royal Bank of Canada) as part of amending and restating existing agreements.
• A substantial portion of QH Hungary's shares (3,635,112 shares) remain pledged under various agreements, including a margin loan and prepaid variable share forward transactions.

Risks

• The value of the shares pledged as collateral could fluctuate, potentially impacting QH Hungary's obligations under the margin loan and prepaid variable share forward transactions.
• QH Hungary's ability to meet its settlement obligations (either by delivering shares or cash) depends on future market conditions and the performance of Quaker Chemical Corporation's stock.
• The requirement for Counterparty to execute a Consent to the Margin Loan Agreement is an additional condition for the Dealer's obligation, which could pose a risk if not met.

Future Outlook

QH Hungary aims to maintain an opportunity to share in Quaker Chemical Corporation's future growth through these transactions, while also extending settlement dates and raising financing. The settlement dates for the forward transactions are set for late 2027 to early 2028.

Management Comments

• "These transactions were designed for QH Hungary to extend the settlement date in the case of the November 2025 A&R Supplemental Confirmations and, in the case of the New Supplemental Confirmations, raise financing while maintaining an opportunity to share in the Issuer's future growth."

Industry Context

na

Related Party Transactions

• QH Hungary Holdings Limited is a wholly-owned subsidiary of Gulf Hungary Holding Korlatolt Felelossegu Tarsasag.
• Gulf Hungary is owned by Gulf Houghton, which is a subsidiary of Gulf Oil International, owned by Amas Holding SPF, beneficially owned by multiple members of the Hinduja family.

Stakeholder Impact

• Shareholders (Quaker Chemical): The filing indicates a significant block of shares (21.0%) remains under the control of the reporting persons, subject to various financial arrangements. The forward contracts could lead to share deliveries or cash settlements in the future, potentially impacting market liquidity or share price depending on the settlement method and market conditions at that time.
• Reporting Persons (Gulf Hungary/QH Hungary): The transactions provide financing and extend settlement dates, offering financial flexibility and the opportunity to participate in future share price appreciation up to the cap. However, they also incur costs and involve pledging a substantial portion of their holdings.
• Lenders (Citibank/RBC): The banks are involved in significant financial transactions, receiving payments and shares for amendments, and providing prepayments for new forward contracts, secured by pledged shares.

Next Steps

• QH Hungary will continue to manage its obligations under the various prepaid variable share forward transactions and margin loan agreements.
• Settlement of the new and amended forward transactions will occur between November 29, 2027, and January 3, 2028.
• Counterparty must execute a Consent to the Margin Loan Agreement for the Dealer's obligation to be satisfied.

Key Dates

Recommendation

This filing primarily concerns the financial arrangements of a significant shareholder (QH Hungary/Gulf Hungary) regarding their existing stake in Quaker Chemical Corporation. It details amendments to prepaid variable share forward transactions, including payments made, shares delivered, and new financing raised. While these transactions provide financial flexibility for the reporting entity and extend settlement dates, they do not directly reflect on the operational performance or strategic direction of Quaker Chemical Corporation itself. The 21.0% beneficial ownership remains consistent. Therefore, for an investor focused on Quaker Chemical's fundamentals, this filing does not present new information that would warrant a change in investment thesis, suggesting a "hold" recommendation based solely on this specific disclosure.

Keywords

Quaker Chemical Corporation, QH Hungary Holdings Limited, Gulf Hungary Holding, Schedule 13D, SEC filing, prepaid variable share forward, equity derivatives, financing, share pledge, beneficial ownership, Citibank, Royal Bank of Canada, common stock, corporate governance, investment